221 related articles for article (PubMed ID: 17127041)
21. Insulin alters nuclear factor-lambdaB and peroxisome proliferator-activated receptor-gamma protein expression induced by glycated bovine serum albumin in vascular smooth-muscle cells.
De Oliveira C; Colette C; Monnier L; Descomps B; Pares-Herbute N
J Lab Clin Med; 2005 Mar; 145(3):144-50. PubMed ID: 15871306
[TBL] [Abstract][Full Text] [Related]
22. Oxidative stress regulates IGF1R expression in vascular smooth-muscle cells via p53 and HDAC recruitment.
Kavurma MM; Figg N; Bennett MR; Mercer J; Khachigian LM; Littlewood TD
Biochem J; 2007 Oct; 407(1):79-87. PubMed ID: 17600529
[TBL] [Abstract][Full Text] [Related]
23. Pathological roles of advanced glycation end product receptors SR-A and CD36.
Horiuchi S; Unno Y; Usui H; Shikata K; Takaki K; Koito W; Sakamoto Y; Nagai R; Makino K; Sasao A; Wada J; Makino H
Ann N Y Acad Sci; 2005 Jun; 1043():671-5. PubMed ID: 16037291
[TBL] [Abstract][Full Text] [Related]
24. Effects of magnolol (5,5'-diallyl-2,2'-dihydroxybiphenyl) on diabetic nephropathy in type 2 diabetic Goto-Kakizaki rats.
Sohn EJ; Kim CS; Kim YS; Jung DH; Jang DS; Lee YM; Kim JS
Life Sci; 2007 Jan; 80(5):468-75. PubMed ID: 17070554
[TBL] [Abstract][Full Text] [Related]
25. Nox1-based NADPH oxidase-derived superoxide is required for VSMC activation by advanced glycation end-products.
San Martin A; Foncea R; Laurindo FR; Ebensperger R; Griendling KK; Leighton F
Free Radic Biol Med; 2007 Jun; 42(11):1671-9. PubMed ID: 17462535
[TBL] [Abstract][Full Text] [Related]
26. CD36 is not involved in scavenger receptor-mediated endocytic uptake of glycolaldehyde- and methylglyoxal-modified proteins by liver endothelial cells.
Nakajou K; Horiuchi S; Sakai M; Hirata K; Tanaka M; Takeya M; Kai T; Otagiri M
J Biochem; 2005 May; 137(5):607-16. PubMed ID: 15944414
[TBL] [Abstract][Full Text] [Related]
27. Antioxidants and an inhibitor of advanced glycation ameliorate death of retinal microvascular cells in diabetic retinopathy.
Yatoh S; Mizutani M; Yokoo T; Kozawa T; Sone H; Toyoshima H; Suzuki S; Shimano H; Kawakami Y; Okuda Y; Yamada N
Diabetes Metab Res Rev; 2006; 22(1):38-45. PubMed ID: 15892182
[TBL] [Abstract][Full Text] [Related]
28. Upregulation of the ligand-RAGE pathway via the angiotensin II type I receptor is essential in the pathogenesis of diabetic atherosclerosis.
Ihara Y; Egashira K; Nakano K; Ohtani K; Kubo M; Koga J; Iwai M; Horiuchi M; Gang Z; Yamagishi S; Sunagawa K
J Mol Cell Cardiol; 2007 Oct; 43(4):455-64. PubMed ID: 17761193
[TBL] [Abstract][Full Text] [Related]
29. Metformin and exercise reduce muscle FAT/CD36 and lipid accumulation and blunt the progression of high-fat diet-induced hyperglycemia.
Smith AC; Mullen KL; Junkin KA; Nickerson J; Chabowski A; Bonen A; Dyck DJ
Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E172-81. PubMed ID: 17374701
[TBL] [Abstract][Full Text] [Related]
30. Phenotypic modulation of mesenteric vascular smooth muscle cells from type 2 diabetic rats is associated with decreased caveolin-1 expression.
Carrillo-Sepulveda MA; Matsumoto T
Cell Physiol Biochem; 2014; 34(5):1497-506. PubMed ID: 25322824
[TBL] [Abstract][Full Text] [Related]
31. Lipogenesis in arterial wall and vascular smooth muscle cells of Psammomys obesus: its regulation and abnormalities in diabetes.
Hamlat N; Negazzi S; Forcheron F; Bricca G; Beylot M; Aouichat-Bouguerra S
Diabetes Metab; 2010 Jun; 36(3):221-8. PubMed ID: 20303812
[TBL] [Abstract][Full Text] [Related]
32. Pigment epithelium-derived factor (PEDF) prevents platelet activation and aggregation in diabetic rats by blocking deleterious effects of advanced glycation end products (AGEs).
Yamagishi S; Matsui T; Takenaka K; Nakamura K; Takeuchi M; Inoue H
Diabetes Metab Res Rev; 2009 Mar; 25(3):266-71. PubMed ID: 19165765
[TBL] [Abstract][Full Text] [Related]
33. Insulin-like growth factor-1 receptor expression masks the antiinflammatory and glucose uptake capacity of insulin in vascular smooth muscle cells.
Engberding N; San Martín A; Martin-Garrido A; Koga M; Pounkova L; Lyons E; Lassègue B; Griendling KK
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):408-15. PubMed ID: 19122171
[TBL] [Abstract][Full Text] [Related]
34. RAGE upregulation and nuclear factor-kappaB activation associated with ageing rat cardiomyocyte dysfunction.
Gao ZQ; Yang C; Wang YY; Wang P; Chen HL; Zhang XD; Liu R; Li WL; Qin XJ; Liang X; Hai CX
Gen Physiol Biophys; 2008 Sep; 27(3):152-8. PubMed ID: 18981529
[TBL] [Abstract][Full Text] [Related]
35. Advanced glycation end products accelerate ischemia/reperfusion injury through receptor of advanced end product/nitrative thioredoxin inactivation in cardiac microvascular endothelial cells.
Liu Y; Ma Y; Wang R; Xia C; Zhang R; Lian K; Luan R; Sun L; Yang L; Lau WB; Wang H; Tao L
Antioxid Redox Signal; 2011 Oct; 15(7):1769-78. PubMed ID: 21126209
[TBL] [Abstract][Full Text] [Related]
36. C-reactive protein upregulates receptor for advanced glycation end products expression and alters antioxidant defenses in rat endothelial progenitor cells.
Chen J; Huang L; Song M; Yu S; Gao P; Jing J
J Cardiovasc Pharmacol; 2009 May; 53(5):359-67. PubMed ID: 19276989
[TBL] [Abstract][Full Text] [Related]
37. Advanced glycation end products in diabetic patients with optimized glycaemic control and their effects on endothelial reactivity: possible implications in venous graft failure.
Chello M; Spadaccio C; Lusini M; Covino E; Blarzino C; De Marco F; Di Domenico F; Coccia R
Diabetes Metab Res Rev; 2009 Jul; 25(5):420-6. PubMed ID: 19405075
[TBL] [Abstract][Full Text] [Related]
38. Advanced glycation end-products enhance calcification in vascular smooth muscle cells.
Ren X; Shao H; Wei Q; Sun Z; Liu N
J Int Med Res; 2009; 37(3):847-54. PubMed ID: 19589269
[TBL] [Abstract][Full Text] [Related]
39. Effects of KIOM-79 on hyperglycemia and diabetic nephropathy in type 2 diabetic Goto-Kakizaki rats.
Kim CS; Sohn EJ; Kim YS; Jung DH; Jang DS; Lee YM; Kim DH; Kim JS
J Ethnopharmacol; 2007 May; 111(2):240-7. PubMed ID: 17194556
[TBL] [Abstract][Full Text] [Related]
40. Expression of receptors for advanced glycosylated end-products in renal disease.
Abel M; Ritthaler U; Zhang Y; Deng Y; Schmidt AM; Greten J; Sernau T; Wahl P; Andrassy K; Ritz E
Nephrol Dial Transplant; 1995; 10(9):1662-7. PubMed ID: 8559486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
